Eric M Dube's Net Worth
$6.98 Million
Who is Eric M Dube?
Eric M Dube has an estimated net worth of $6.98 Million. This is based on reported shares across multiple companies, which include Travere Therapeutics, Inc., and Reneo Pharmaceuticals, Inc..
SEC CIK
Eric M Dube's CIK is 0001763494
Past Insider Trading and Trends
2020 was Eric M Dube's most active year for acquiring shares with 6 total transactions. Eric M Dube's most active month to acquire stocks was the month of December. 2021 was Eric M Dube's most active year for disposing of shares, totalling 10 transactions. Eric M Dube's most active month to dispose stocks was the month of December. 2019 saw Eric M Dube paying a total of $0.00 for 506,000 shares, this is the most they've acquired in one year. In 2022 Eric M Dube cashed out on 34,850 shares for a total of $984,473.34, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Travere Therapeutics, Inc. (TVTX) Snapshot price: $10.98
CHIEF EXECUTIVE OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.24% | 11.38K |
$11.52 | -$243,360.00 | 361.98K |
Scheduled
|
Sep 5 - Sep 9
| ||
Form 4
| +49.37% | 115.88K |
$8.70 | -$166,435.06 | 350.6K |
Jan 31 - Feb 1
| |||
Form 4
| -3.25% | -7.87K |
$8.96 | -$70,542.08 | 234.72K |
Jan 23
| |||
Form 4
| +2.30% | 5.45K |
$14.71 | -$65,533.05 | 242.59K |
Aug 31 - Sep 5
| |||
Form 4
| +60.40% | 89.3K |
$22.25 | -$182,361.00 | 237.15K |
Scheduled
|
Jan 31 - Feb 1
| ||
Form 4
| -4.18% | -6.44K |
$21.50 | -$138,503.00 | 147.85K |
Scheduled
|
Jan 24
| ||
Form 4
| -3.52% | -5.63K |
$20.75 | -$116,718.75 | 154.29K |
Scheduled
|
Jan 5
| ||
Form 4
| -2.93% | -4.83K |
$27.84 | -$134,522.88 | 159.91K |
Scheduled
|
Feb 10
| ||
Form 4
| +25.08% | 33.03K |
$27.40 | -$131,876.20 | 164.75K |
Scheduled
|
Jan 31
| ||
Form 4
| -5.64% | -7.87K |
$24.98 | -$196,667.54 | 131.71K |
Scheduled
|
Jan 24
| ||
Form 4
| -11.05% | -17.33K |
$30.08 | -$521,406.72 | 139.58K |
Scheduled
|
Jan 4 - Jan 5
| ||
Form 4
| +6.56% | 9.66K |
$17.12 | -$134,142.13 | 156.91K |
Aug 13 - Aug 17
| |||
Form 4
| -6.10% | -9.56K |
$14.62 | -$139,796.98 | 147.25K |
Scheduled
|
Jun 1 - Jun 2
| ||
Form 4
| -5.78% | -9.63K |
$31.50 | -$303,170.87 | 156.81K |
Scheduled
|
Feb 5 - Feb 8
| ||
Form 4
| +11.75% | 17.5K |
—
|
—
| 166.44K |
Feb 3
| |||
Form 4
| -1.59% | -2.41K |
$28.91 | -$69,557.46 | 148.94K |
Scheduled
|
Feb 3
| ||
Form 4
| +4.32% | 6.27K |
$29.91 | -$261,266.72 | 151.34K |
Scheduled
|
Jan 31 - Feb 2
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 4
| +65.20% | 57.26K |
—
|
—
| 145.08K |
Jan 21
| |||
Form 4
| -7.26% | -6.88K |
$26.83 | -$184,483.08 | 87.82K |
Scheduled
|
Jan 5 - Jan 6
| ||
Form 4
| +22.19% | 17.2K |
$19.28 | -$208,319.37 | 94.69K |
Sep 18 - Sep 21
| |||
Form 4
| +82.35% | 35K |
—
|
—
| 77.5K |
Jan 31
| |||
Form 4
| -15.00% | -7.50K |
$14.54 | -$109,050.00 | 42.5K |
Scheduled
|
Jan 7 - Jan 8
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
∞
| 50K |
—
|
—
| 50K |
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Reneo Pharmaceuticals, Inc. (RPHM) Snapshot price: $1.43
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |